MAALOX PLUS

This brand name is authorized in Cyprus, Hong Kong SAR China, Ireland, Israel, Malta, Nigeria, South Africa, UK.

Active ingredients

The drug MAALOX PLUS contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 5QB0T2IUN0 - ALUMINUM HYDROXIDE
 

Aluminium hydroxide is a slow-acting antacid. It is used to provide symptomatic relief in gastric hyperacidity. In addition, the antipeptic and demulcent activity of aluminium hydroxide helps to protect inflamed gastric mucosa against further irritation by gastric secretions.

 
Read more about Aluminium hydroxide
2
UNII NBZ3QY004S - MAGNESIUM HYDROXIDE
 

Magnesium hydroxide is practically insoluble in water and solution is not effected until the hydroxide reacts with hydrochloric acid in the stomach to form magnesium chloride. Its neutralising action is almost equal to that of sodium bicarbonate. When the dose is in excess of that required to neutralise the acid the intragastric pH may reach pH 8 or 9. Acid rebound following magnesium hydroxide is clinically insignificant. Magnesium hydroxide has an indirect cathartic effect resulting from water retention in the intestinal lumen.

 
Read more about Magnesium hydroxide
3
UNII 92RU3N3Y1O - DIMETHICONE
 

Simethicone is a chemically inert, non-systemic gastric defoaming agent that works by altering the elasticity of interfaces of mucus-embedded bubbles in the gastrointestinal tract. The gas bubbles are thus broken down or coalesced and in this form gas is more easily eliminated through eructation or passing flatus.

 
Read more about Simethicone

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 MAALOX PLUS Oral suspension MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A02AF02 Ordinary salt combinations and antiflatulents A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02A Antacids → A02AF Antacids with antiflatulents
Discover more medicines within A02AF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
GB Medicines & Healthcare Products Regulatory Agency 341565, 347164, 49276
HK Department of Health Drug Office 01550
IL מִשְׂרַד הַבְּרִיאוּת 1305, 5243
MT Medicines Authority MA1470/00601, MA1470/00602
NG Registered Drug Product Database A4-3349
Switch country to Nigeria in order to find specific presentations of MAALOX PLUS
ZA Health Products Regulatory Authority R/11.4.3/74, R/11.4.3/75

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.